Bank of New York Mellon Corp Has $2.14 Million Position in Mesa Laboratories, Inc. (MLAB)

Bank of New York Mellon Corp lowered its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 3.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 17,234 shares of the medical instruments supplier’s stock after selling 529 shares during the quarter. Bank of New York Mellon Corp owned about 0.46% of Mesa Laboratories worth $2,142,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in MLAB. Conestoga Capital Advisors LLC lifted its stake in Mesa Laboratories by 13.6% in the fourth quarter. Conestoga Capital Advisors LLC now owns 423,804 shares of the medical instruments supplier’s stock valued at $52,679,000 after buying an additional 50,577 shares in the last quarter. Victory Capital Management Inc. lifted its stake in Mesa Laboratories by 17.2% in the fourth quarter. Victory Capital Management Inc. now owns 172,774 shares of the medical instruments supplier’s stock valued at $21,476,000 after buying an additional 25,306 shares in the last quarter. Thomson Horstmann & Bryant Inc. lifted its stake in Mesa Laboratories by 14.5% in the fourth quarter. Thomson Horstmann & Bryant Inc. now owns 88,379 shares of the medical instruments supplier’s stock valued at $10,985,000 after buying an additional 11,164 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its stake in Mesa Laboratories by 149.5% in the third quarter. Schwab Charles Investment Management Inc. now owns 11,976 shares of the medical instruments supplier’s stock valued at $1,789,000 after buying an additional 7,176 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in Mesa Laboratories by 166.7% in the fourth quarter. The Manufacturers Life Insurance Company now owns 6,783 shares of the medical instruments supplier’s stock valued at $843,000 after buying an additional 4,240 shares in the last quarter. 72.93% of the stock is currently owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

Shares of MLAB stock opened at $169.65 on Tuesday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.64 and a current ratio of 2.37. The firm has a market capitalization of $636.29, a PE ratio of 40.20 and a beta of 0.50. Mesa Laboratories, Inc. has a 12 month low of $122.35 and a 12 month high of $170.69.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings data on Monday, February 5th. The medical instruments supplier reported ($0.24) EPS for the quarter, missing the Zacks’ consensus estimate of $0.53 by ($0.77). The business had revenue of $23.67 million during the quarter, compared to the consensus estimate of $23.10 million. Mesa Laboratories had a positive return on equity of 9.20% and a negative net margin of 3.82%. analysts anticipate that Mesa Laboratories, Inc. will post 5.66 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 15th. Stockholders of record on Thursday, May 31st will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date of this dividend is Wednesday, May 30th. Mesa Laboratories’s dividend payout ratio is presently 15.17%.

A number of research analysts have weighed in on MLAB shares. ValuEngine raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. BidaskClub raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating in a research note on Thursday, March 15th. TheStreet lowered shares of Mesa Laboratories from a “b-” rating to a “c” rating in a research note on Wednesday, February 7th. Finally, Zacks Investment Research raised shares of Mesa Laboratories from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 9th.

In other news, Director Robert V. Dwyer sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 14th. The shares were sold at an average price of $144.01, for a total value of $720,050.00. Following the sale, the director now owns 68,521 shares of the company’s stock, valued at $9,867,709.21. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director John Bradley Schmieder sold 3,000 shares of the business’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $132.27, for a total transaction of $396,810.00. Following the completion of the sale, the director now directly owns 77,869 shares in the company, valued at approximately $10,299,732.63. The disclosure for this sale can be found here. In the last three months, insiders sold 12,000 shares of company stock worth $1,668,860. 15.70% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: “Bank of New York Mellon Corp Has $2.14 Million Position in Mesa Laboratories, Inc. (MLAB)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/17/bank-of-new-york-mellon-corp-has-2-14-million-position-in-mesa-laboratories-inc-mlab.html.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.

Want to see what other hedge funds are holding MLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mesa Laboratories, Inc. (NASDAQ:MLAB).

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply